Virus vaccines: proteins prefer prolines-Reference-Cited by-同舟云学术

Virus vaccines: proteins prefer prolines

Published:2021-03 Issue:3 Volume:29 Page:327-333
ISSN:1931-3128
Container-title:Cell Host & Microbe
language:en
Short-container-title:Cell Host & Microbe

Author:

Sanders Rogier W.,Moore John P.

Funder

Bill and Melinda Gates Foundation

Horizon 2020 Framework Programme

Nederlandse Organisatie voor Wetenschappelijk Onderzoek

Horizon 2020

National Institutes of Health

Publisher

Elsevier BV

Reference39 articles.

1. Introduction of two prolines and removal of the polybasic cleavage site leads to optimal efficacy of a recombinant spike based SARS-CoV-2 vaccine in the mouse model;Amanat;bioRxiv,2020

2. Structure and immunogenicity of pre-fusion-stabilized human metapneumovirus F glycoprotein;Battles;Nat. Commun.,2017

3. A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structure;Binley;J. Virol.,2000

4. Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses;Bos;NPJ Vaccines,2020

5. Summary of the Vaccines and Related Biological Products Advisory Committee meeting held to consider evaluation of vaccine candidates for the prevention of respiratory syncytial virus disease in RSV-naïve infants;Browne;Vaccine,2020

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Precise targeting of HIV broadly neutralizing antibody precursors in humans;Science;2025-05-15

2. Structure-guided design of a prefusion GPC trimer induces neutralizing responses against LASV;npj Vaccines;2025-02-22

3. Structure of endogenous Pfs230:Pfs48/45 in complex with potent malaria transmission-blocking antibodies;2025-02-15

4. Experimental medicine study with stabilised native-like HIV-1 Env immunogens drives long-term antibody responses, but lacks neutralising breadth;eBioMedicine;2025-02

5. An overview of recombinant vaccines against viral, fungal, bacterial and parasitic diseases;International Journal of New Findings in Health and Educational Sciences (IJHES);2024-12-29